In plain words
GABA is one of the brain's main calming chemicals. The GABA-A receptor is one of the places it acts. In pregnancy, a progesterone byproduct called helps this receptor work well. After birth, that support drops quickly. Animal research suggests the receptor's makeup also changes during pregnancy and needs time to recover afterward. Researchers think this gap may play a part in the mood and sleep changes some mothers notice. The idea is still being studied, and it does not explain every case. It is not a diagnosis, and no home test measures it. Mothers may hear about it in talks about , , or medicine choices after birth.
The deeper version
GABA-A receptors are pentameric chloride channels whose opening hyperpolarizes neurons. Neurosteroids, including allopregnanolone, a metabolite of progesterone, act as positive allosteric modulators at extrasynaptic receptors containing delta subunits, which increases tonic inhibition. Allopregnanolone rises across pregnancy and falls sharply after delivery. Maguire and Mody (Neuron, 2008) reported in rodent models that delta-subunit expression is downregulated during pregnancy and must recover postpartum. That produces a window of relative GABAergic hypofunction. Human evidence is indirect. Serum allopregnanolone and postpartum mood have been associated in several cohorts, with inconsistent results and no established causal link. , a synthetic form of allopregnanolone, was approved by the US Food and Drug Administration in 2019 for postpartum depression. The debate is whether this mechanism explains postpartum depression in some people, or is one of several contributing pathways.
Where it comes up
- Postpartum depressionPostpartum: Mind
- Baby blues: the first two weeksPostpartum: Mind
- Therapy and medication after birth: what the options arePostpartum: Mind
- Vivid dreams, mood swings, and crying at commercialsPregnancy: Mind and Life
- Anxiety in pregnancyPregnancy: Mind and Life
What mothers here say about GABA-A receptor
No one has posted under this term yet.
Sources
- Maguire J and Mody I — GABA(A)R plasticity during pregnancy: relevance to postpartum depression. Neuron, 2008
- US Food and Drug Administration — Approval of brexanolone for postpartum depression (2019)